Toru Wakamatsu

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Topics

Transforming Growth Factor

Histone Deacetylase

Hodgkin Lymphoma

Top Venues

Cancer innovation

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Satoru Sasagawa, Jun Kumai, Toru Wakamatsu, Yoshihiro Yui
Improvement of histone deacetylase inhibitor efficacy by SN38 through TWIST1 suppression in synovial sarcoma. Cancer innovation 3 (2) (2024)
Satoru Sasagawa, Jun Kumai, Toru Wakamatsu, Yoshihiro Yui
Improvement of histone deacetylase inhibitor efficacy by SN38 through TWIST1 suppression in synovial sarcoma. Cancer innovation 3 (2) (2024)
Takuo Yamai, Kenji Ikezawa, Naotoshi Sugimoto, Makiko Urabe, Yugo Kai, Ryoji Takada, Tasuku Nakabori, Hiroyuki Uehara, Takahisa Kawamura, Kei Kunimasa, Sachiko Yamamoto, Toru Wakamatsu, Takuji Hayashi, Yoji Kukita, Fumie Fujisawa, Tazuko Inoue, Yuko Yamaguchi, Tomoyuki Yamasaki, Keiichirou Honma, Kazuyoshi Ohkawa
Utility of Comprehensive Genomic Profiling Tests for Patients with Incurable Pancreatic Cancer in Clinical Practice. Cancers 15 (3) (2023)
Takuo Yamai, Kenji Ikezawa, Naotoshi Sugimoto, Makiko Urabe, Yugo Kai, Ryoji Takada, Tasuku Nakabori, Hiroyuki Uehara, Takahisa Kawamura, Kei Kunimasa, Sachiko Yamamoto, Toru Wakamatsu, Takuji Hayashi, Yoji Kukita, Fumie Fujisawa, Tazuko Inoue, Yuko Yamaguchi, Tomoyuki Yamasaki, Keiichirou Honma, Kazuyoshi Ohkawa
Utility of Comprehensive Genomic Profiling Tests for Patients with Incurable Pancreatic Cancer in Clinical Practice. Cancers 15 (3) (2023)
Hironari Tamiya, Naoko Urushihara, Kazuko Shizuma, Hisataka Ogawa, Sho Nakai, Toru Wakamatsu, Satoshi Takenaka, Shigeki Kakunaga
SHARPIN Enhances Ferroptosis in Synovial Sarcoma Cells via NF-κB- and PRMT5-Mediated PGC1α Reduction. Cancers 15 (13) (2023)
Yoshinori Imura, Satoshi Takenaka, Hidetatsu Outani, Takaaki Nakai, Naohiro Yasuda, Sho Nakai, Toru Wakamatsu, Hironari Tamiya, Seiji Okada
Impact of Surgery and Chemotherapy on Metastatic Extrauterine Leiomyosarcoma. Current oncology (Toronto, Ont.) 29 (4) (2022)
Toshiyuki Takemori, Teruya Kawamoto, Hitomi Hara, Naomasa Fukase, Shuichi Fujiwara, Ikuo Fujita, Takuya Fujimoto, Masayuki Morishita, Kazumichi Kitayama, Shunsuke Yahiro, Tomohiro Miyamoto, Masanori Saito, Jun Sugaya, Katsuhiro Hayashi, Hiroyuki Kawashima, Tomoaki Torigoe, Tomoki Nakamura, Hiroya Kondo, Toru Wakamatsu, Munenori Watanuki, Munehisa Kito, Satoshi Tsukushi, Akihito Nagano, Hidetatsu Outani, Shunichi Toki, Shunji Nishimura, Hiroshi Kobayashi, Itsuo Watanabe, Yusuke Demizu, Ryohei Sasaki, Takumi Fukumoto, Takahiro Niikura, Ryosuke Kuroda, Toshihiro Akisue
Clinical Outcome of Patients with Pelvic and Retroperitoneal Bone and Soft Tissue Sarcoma: A Retrospective Multicenter Study in Japan. Cancers 14 (12) (2022)
Hidetatsu Outani, Satoshi Takenaka, Kenichiro Hamada, Yoshinori Imura, Shigeki Kakunaga, Hironari Tamiya, Toru Wakamatsu, Norifumi Naka, Takafumi Ueda, Nobuhito Araki
A long-term follow-up study of extracorporeal irradiated autografts in limb salvage surgery for malignant bone and soft tissue tumors: A minimum follow-up of 10 years after surgery. Journal of surgical oncology 121 (8) (2020)
Sho Nakai, Hironari Tamiya, Yoshinori Imura, Takaaki Nakai, Naohiro Yasuda, Toru Wakamatsu, Takaaki Tanaka, Hidetatsu Outani, Satoshi Takenaka, Kenichiro Hamada, Akira Myoui, Nobuhito Araki, Takafumi Ueda, Hideki Yoshikawa, Norifumi Naka
Eribulin Suppresses Clear Cell Sarcoma Growth by Inhibiting Cell Proliferation and Inducing Melanocytic Differentiation Both Directly and Via Vascular Remodeling. Molecular cancer therapeutics 19 (3) (2019)
Hiroshi Kobayashi, Shintaro Iwata, Toru Wakamatsu, Keiko Hayakawa, Tsukasa Yonemoto, Junji Wasa, Hiroyuki Oka, Takafumi Ueda, Sakae Tanaka
Efficacy and safety of trabectedin for patients with unresectable and relapsed soft-tissue sarcoma in Japan: A Japanese Musculoskeletal Oncology Group study. Cancer 126 (6) (2019)